Anti-proliferative effect of Juglone from Juglans mandshurica Maxim on human leukemia cell HL-60 by inducing apoptosis through the mitochondria-dependent pathway

European Journal of Pharmacology

Volumn 645, Issue 1-3, 2010, Pages 14-22

  Xu, Hua Li ^a   Yu, Xiao Feng ^a   Qu, Shao Chun ^a   Zhang, Rui ^a   Qu, Xiang Ru ^a   Chen, Yan Ping ^a   Ma, Xing Yuan ^a   Sui, Da Yuan ^a  

^a JILIN UNIVERSITY   (China)

Author keywords

Apoptosis; Caspase; HL 60; Juglone; Mitochondrial membrane potential

Indexed keywords

CASPASE 3; CASPASE 9; CYTOCHROME C; JUGLONE; MESSENGER RNA; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; PROTEIN BAX; PROTEIN BCL 2;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CELL STRAIN HL 60; CELL SURVIVAL; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOPLASM; CYTOTOXICITY TEST; DRUG STRUCTURE; ENZYME ACTIVATION; GROWTH INHIBITION; HUMAN; HUMAN CELL; JUGLANDACEAE; JUGLANS MANDSHURICA MAXIM; MITOCHONDRIAL MEMBRANE POTENTIAL; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ANTINEOPLASTIC AGENTS, PHYTOGENIC; APOPTOSIS; APOPTOSIS INDUCING FACTOR; CASPASES; CELL PROLIFERATION; CYTOCHROMES C; DOSE-RESPONSE RELATIONSHIP, DRUG; ENZYME INHIBITORS; HL-60 CELLS; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; JUGLANS; MEMBRANE POTENTIAL, MITOCHONDRIAL; MITOCHONDRIAL PROTEINS; NAPHTHOQUINONES; OLIGOPEPTIDES; POLY(ADP-RIBOSE) POLYMERASES; PROTO-ONCOGENE PROTEINS C-BCL-2; RNA, MESSENGER;

EID: 77956184488     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2010.06.072     Document Type: Article

References (42)

1. Adams J.M., Cory S. The Bcl-2 apoptotic switch in cancer development and therapy. Oncogene 2007, 26:1324-1337.
2. Allen R.T., Hunter W.J., Agrawal D.K. Morphological and biochemical characterization and analysis of apoptosis. J. Pharmacol. Toxicol. Meth. 1997, 37:215-228.
3. Aragane Y., Kulms D., Metze D., Wilkes G., Poppelmann B., Luger T.A., Schwarz T. Ultraviolet light induces apoptosis via direct activation of CD95 (Fas/APO-1) independently of its ligand CD95L. J. Cell Biol. 1998, 140:171-182.
4. Babich H., Stern A. In vitro cytotoxicities of 1, 4-naphthoquinone and hydroxylated 1, 4-naphthoquinones to replicating cells. J. Appl. Toxicol. 1993, 13:353-358.
5. Basu A., Castle V.P., Bouziane M., Bhalla K., Haldar S. Crosstalk between extrinsic and intrinsic cell death pathways in pancreatic cancer: synergistic action of estrogen metabolite and ligands of death receptor family. Cancer Res. 2006, 66:4309-4318.
6. Bharti A.C., Takada Y., Shishodia S., Aggarwal B.B. Evidence that receptor activator of nuclear factor (NF)-kappaB ligand can suppress cell proliferation and induce apoptosis through activation of a NF-kappaB-independent and TRAF6-dependent mechanism. J. Biol. Chem. 2004, 279:6065-6076.
7. Bolton J.L., Trush M.A., Penning T.M., Dryhurst G., Monks T.J. Role of quinones in toxicology. Chem. Res. Toxicol. 2000, 13:135-160.
8. Chao S.H., Greenleaf A.L., Price D.H. Juglone, an inhibitor of the peptidyl-prolyl isomerase Pin1, also directly blocks transcription. Nucleic Acids Res. 2001, 29:767-773.
9. Cheng Y.L., Chang W.L., Lee S.C., Liu Y.G., Lin H.C., Chen C.J., Yen C.Y., Yu D.S., Lin S.Z., Harn H.J. Acetone extract of Bupleurum scorzonerifolium inhibits proliferation of A549 human lung cancer cells via inducing apoptosis and suppressing telomerase activity. Life Sci. 2003, 73:2383-2394.
10. Choi B.H., Kim W., Wang Q.C., Kim D.C., Tan S.N., Yong J.W., Kim K.T., Yoon H.S. Kinetin riboside preferentially induces apoptosis by modulating Bcl-2 family proteins and caspase-3 in cancer cells. Cancer Lett. 2008, 261:37-45.
11. Cory S., Adams J.M. The Bcl2 family: regulators of the cellular life-or-death switch. Nat. Rev. Cancer 2002, 2:647-656.
12. Earnshaw W.C., Martins L.M., Kaufmann S.H. Mammalian caspases: structure, activation, substrates, and functions during apoptosis. Annu. Rev. Biochem. 1999, 68:383-424.
13. Hengartner M.O. The biochemistry of apoptosis. Nature 2000, 407:770-776.
14. Hockenbery D.M., Oltvai Z.N., Yin X.M., Milliman C.L., Korsmeyer S.J. Bcl-2 functions in an antioxidant pathway to prevent apoptosis. Cell 1993, 75:241-251.
15. Hsu Y.L., Cho C.Y., Kuo P.L., Huang Y.T., Lin C.C. Plumbagin (5-hydroxy-2-methyl-1, 4-naphthoquinone) induces apoptosis and cell cycle arrest in A549 cells through p53 accumulation via c-Jun NH2-terminal kinase-mediated phosphorylation at serine 15 in vitro and in vivo. J. Pharmacol. Exp. Ther. 2006, 318:484-494.
16. Inbaraj J.J., Chignell C.F. Cytotoxic action of juglone and plumbagin: a mechanistic study using HaCaT keratinocytes. Chem. Res. Toxicol. 2004, 17:55-62.
17. Kamei H., Koide T., Kojima T., Hashimoto Y., Hasegawa M. Inhibition of cell growth in culture by quinones. Cancer Biother. Radiopharm. 1998, 13:185-188.
18. Kang K.H., Lee K.H., Kim M.Y., Choi K.H. Caspase-3-mediated cleavage of the NF-kappa B subunit p65 at the NH2 terminus potentiates naphthoquinone analog-induced apoptosis. J. Biol. Chem. 2001, 276:24638-24644.
19. Kang K.H., Lee J.H., Kim K.C., Ham S.W., Kim M.Y., Choi K.H. Induction of p73beta by a naphthoquinone analog is mediated by E2F-1 and triggers apoptosis in HeLa cells. FEBS Lett. 2002, 522:161-167.
20. Kaufmann S.H., Earnshaw W.C. Induction of apoptosis by cancer chemotherapy. Exp. Cell Res. 2000, 256:42-49.
21. Kaufmann S.H., Hengartner M.O. Programmed cell death: alive and well in the new millennium. Trends Cell Biol. 2001, 11:526-534.
22. Kim S.H., Lee K.S., Son J.K., Je G.H., Lee J.S., Lee C.H., Cheong C.J. Cytotoxic compounds from the roots of Juglans mandshurica. J. Nat. Prod. 1998, 61:643-645.
23. Kim R., Emi M., Tanabe K. Role of mitochondria as the gardens of cell death. Cancer Chemother. Pharmacol. 2006, 57:545-553.
24. Lee K.H. Anticancer drug design based on plant-derived natural products. J. Biomed. Sci. 1999, 6:236-250.
25. Li Z.B., Wang J.Y., Jiang B., Zhang X.L., An L.J., Bao Y.M. Benzobijuglone, a novel cytotoxic compound from Juglans mandshurica, induced apoptosis in HeLa cervical cancer cells. Phytomedicine 2007, 14:846-852.
26. Ly J.D., Grubb D.R., Lawen A. The mitochondrial membrane potential (deltapsi(m)) in apoptosis; an update. Apoptosis 2003, 8:115-128.
27. Monks T.J., Hanzlik R.P., Cohen G.M., Ross D., Graham D.G. Quinone chemistry and toxicity. Toxicol. Appl. Pharmacol. 1992, 112:2-16.
28. Montenegro R.C., Araujo A.J., Molina M.T., Filho J.D., Rocha D.D., Lopez-Montero E., Goulart M.O., Bento E.S., Alves A.P., Pessoa C., de Moraes M.O., Costa-Lotufo L.V. Cytotoxic activity of naphthoquinones with special emphasis on juglone and its 5-O-methyl derivative. Chem. Biol. Interact. 2010, 184:439-448.
29. Munday R., Munday C.M. Induction of quinone reductase and glutathione transferase in rat tissues by juglone and plumbagin. Planta Med. 2000, 66:399-402.
30. Omar S., Lemonnier B., Jones N., Ficker C., Smith M.L., Neema C., Towers G.H., Goel K., Arnason J.T. Antimicrobial activity of extracts of eastern North American hardwood trees and relation to traditional medicine. J. Ethnopharmacol. 2000, 73:161-170.
31. Park S.Y., Cho S.J., Kwon H.C., Lee K.R., Rhee D.K., Pyo S. Caspase-independent cell death by allicin in human epithelial carcinoma cells: involvement of PKA. Cancer Lett. 2005, 224:123-132.
32. Paulsen M.T., Ljungman M. The natural toxin juglone causes degradation of p53 and induces rapid H2AX phosphorylation and cell death in human fibroblasts. Toxicol. Appl. Pharmacol. 2005, 209:1-9.
33. Preston T.J., Abadi A., Wilson L., Singh G. Mitochondrial contributions to cancer cell physiology: potential for drug development. Adv. Drug Deliv. Rev. 2001, 49:45-61.
34. Reed J.C. Apoptosis-regulating proteins as targets for drug discovery. Trends Mol. Med. 2001, 7:314-319.
35. Salvesen G.S., Dixit V.M. Caspase activation: the induced-proximity model. Proc. Natl. Acad. Sci. USA 1999, 96:10964-10967.
36. Sandur S.K., Ichikawa H., Sethi G., Ahn K.S., Aggarwal B.B. Plumbagin (5-hydroxy-2-methyl-1, 4-naphthoquinone) suppresses NF-kappaB activation and NF-kappaB-regulated gene products through modulation of p65 and IkappaBalpha kinase activation, leading to potentiation of apoptosis induced by cytokine and chemotherapeutic agents. J. Biol. Chem. 2006, 281:17023-17033.
37. Sugie S., Okamoto K., Rahman K.M., Tanaka T., Kawai K., Yamahara J., Mori H. Inhibitory effects of plumbagin and juglone on azoxymethane-induced intestinal carcinogenesis in rats. Cancer Lett. 1998, 127:177-183.
38. Sun X.M., MacFarlane M., Zhuang J., Wolf B.B., Green D.R., Cohen G.M. Distinct caspase cascades are initiated in receptor-mediated and chemical-induced apoptosis. J. Biol. Chem. 1999, 274:5053-5060.
39. Thompson C.B. Apoptosis in the pathogenesis and treatment of disease. Science 1995, 267:1456-1462.
40. Wang H., Mao Y., Chen A.Y., Zhou N., LaVoie E.J., Liu L.F. Stimulation of topoisomerase II-mediated DNA damage via a mechanism involving protein thiolation. Biochemistry 2001, 40:3316-3323.
41. Wang C.C., Chiang Y.M., Sung S.C., Hsu Y.L., Chang J.K., Kuo P.L. Plumbagin induces cell cycle arrest and apoptosis through reactive oxygen species/c-Jun N-terminal kinase pathways in human melanoma A375.S2 cells. Cancer Lett. 2008, 259:82-98.
42. Zhou P.H., Liu S.Q., Peng H. The effect of hyaluronic acid on IL-1beta-induced chondrocyte apoptosis in a rat model of osteoarthritis. J. Orthop. Res. 2008, 26:1643-1648.